Recruiting
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.
ClinicalTrials.gov IDNCT05438511
PhaseNot Applicable
Enrollment85
SponsorMemorial Sloan Kettering Cancer Center
Age18 Years
SexALL
Conditions studied
Breast Cancer
About this study
The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.
Interventions
- Behavioral: Focus group — A semi-structured focus group discussion guide will be developed with question probes that cover 1) contextual factors, 2) barriers to implementation, and 3) facilitators to implementation, with secondary probing questions.
- Behavioral: Organizational Readiness for Implementing Change — measures the extent to which organizational members are prepared to implement organizational change. The ORIC tool asks participants to rate their level of agreement with 12 statements pertaining to organizational readiness for change (change commitment and change efficacy) on a 5-point Likert Scale.
Primary outcomes
- Identify barriers for breast cancer diagnosis in Tanzania. (1 year)
Eligibility information
Participant Inclusion Criteria for interviews and focus group discussions (Aims 1 and 2):
* Breast cancer survivor, patient advocate or key healthcare personnel
* Key healthcare personnel are defined as hospital and laboratory leaders, pathologists, laboratory scientists and technicians, oncologists, nurses, and surgeons, with:
* \>12 months of employment at the affiliated institution
* Administrative or clinical involvement in the delivery of breast cancer care services.
* Age 18 years and above
* Permanent residents or citizens of Tanzania
* Participant and/or LAR willing and able to consent
* Fluent in Swahili and/or English by self-report
Participant Exclusion Criteria:
* Key stakeholder not residing at their particular institutions during data collection will be excluded.
Eligibility criteria for Chart Reviews (Aim 1)
Inclusion Criteria for chart review:
* Age 18 years and above
* Permanent residents or citizens of Tanzania
* Received breast cancer diagnosis
Exclusion Criteria for chart review:
* Participants less than 18 years of age
Study locations
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York 10065 United States
- Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.